Short Interest in Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Drops By 13.1%
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) was the recipient of a significant decrease in short interest in March. As of March 31st, there was short interest totalling 6,440,000 shares, a decrease of 13.1% from the March 15th total of 7,410,000 shares. Currently, 6.5% of the shares of the company are sold short. Based on […]